Osang Healthcare Co.,Ltd (036220.KQ) stock: key figures, P/E, revenue and dividend

Health Care · South Korea

Price
5,120.00 KRW
Market cap
70.40 bn KRW
P/E (2025)
22.65
P/S (2025)
0.55
Dividend yield
3.91 %
Net margin
2.42 %
Return on equity (ROE)
1.11 %
Return on assets (ROA)
0.92 %

Osang Healthcare Co.,Ltd financials

Fiscal year20242025
Revenue80.49 bn KRW128.63 bn KRW
Gross profit25.57 bn KRW57.14 bn KRW
Operating income-24.80 bn KRW2.43 bn KRW
EBIT-23.03 bn KRW3.64 bn KRW
Net income-11.36 bn KRW3.11 bn KRW
Diluted EPS – continuing operations-828.82 KRW226.09 KRW

Full history since 2008, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Osang Healthcare Co.,Ltd

Osang Healthcare Co.,Ltd researches, develops, and sells various diagnostic biosensors in South Korea and internationally. The company offers diagnostic biosensors for blood glucose, hemoglobin A1c, cholesterol, immuno diagnosis, molecular diagnosis, and others. It also exports its products to approximately 110 countries worldwide. The company was formerly known as Infopia Co., Ltd. and changed its name to Osang Healthcare Co.,Ltd in April 2017. Osang Healthcare Co.,Ltd was founded in 1996 and is headquartered in Anyang-si, South Korea.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.